Robert Cornog
Robert Cornog has more than 26 years of experience in product development and process design across a broad range of dosage forms and technologies. His work focuses on applying manufacturing science and risk-based approaches to product development, including the transfer of late-stage and commercial drug product programmes. At Quotient Sciences, he provides technical and scientific support across product development and manufacturing activities.
ArticlePoor solubility as a programme-level risk: selecting formulations for clinical performance and scalable development
In this whitepaper, explore how human pharmacokinetic data can guide formulation decisions, minimise development risk and help teams select the simplest viable approach for poorly soluble molecules.


